Modulators of LXR

Details for Australian Patent Application No. 2002351412 (hide)

International Classifications

Event Publications

20 March 2003 Complete Application Filed

Priority application(s): 60/342,707 21.12.01 US

4 September 2003 Application Open to Public Inspection

Published as AU-B-2002351412

9 September 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

27 July 2006 Section 223 Application Received

X-CEPTOR THERAPEUTICS, INC. An application to extend the time from 21 Jul 2004 to 21 Aug 2005 in which to enter the National Phase has been filed . Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 2003

28 September 2006 Section 223 Application Allowed

X-Ceptor Therapeutics, Inc. The time in which to enter the National Phase has been extended to 21 Aug 2005. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 2003

20 May 2010 Application Accepted

Published as AU-B-2002351412

16 September 2010 Standard Patent Sealed

8 March 2012 Assignment Registered

X-Ceptor Therapeutics, Inc. The patent has been assigned to Exelixis Patent Company LLC

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.